Publicaciones en las que colabora con MARTA HERREROS VILLANUEVA (35)

2022

  1. Circulating tumor DNA tracking in patients with pancreatic cancer using next-generation sequencing

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 8, pp. 637-644

2020

  1. CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort

    Molecular Biology Reports, Vol. 47, Núm. 3, pp. 1583-1588

  2. Validation of miR-1228-3p as housekeeping for microRNA analysis in liquid biopsies from colorectal cancer patients

    Biomolecules, Vol. 10, Núm. 1

2019

  1. Correction: Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer (Clinical and Translational Gastroenterology, (2019) 10, e-00031, 10.14309/ctg.0000000000000003)

    Clinical and Translational Gastroenterology

  2. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer

    Clinical and translational gastroenterology, Vol. 10, Núm. 1, pp. e00003

2018

  1. Plasma miRNAs signature validation for early detection of colorectal cancer

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. v106

2017

  1. Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance

    World Journal of Gastroenterology, Vol. 23, Núm. 18, pp. 3367-3373

  2. Pancreatic cancer in lynch syndrome patients

    Journal of Cancer, Vol. 8, Núm. 18, pp. 3667-3674

  3. Triple synchronous gastric tumors: A rare combination diffuse adenocarcinoma, B-cell MALT lymphoma and large cell neuroendocrine carcinoma

    Gastroenterologia y Hepatologia, Vol. 40, Núm. 10, pp. 675-677

2016

  1. Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer

    Annals of Translational Medicine

  2. Immunotherapy in colorectal cancer: What have we learned so far?

    Clinica Chimica Acta, Vol. 460, pp. 78-87

  3. Influence of dopaminergic system genetic variation and lifestyle factors on excessive alcohol consumption

    Alcohol and Alcoholism, Vol. 51, Núm. 3, pp. 258-267

  4. Non-invasive biomarkers in pancreatic cancer diagnosis: What we need versus what we have

    Annals of Translational Medicine, Vol. 4, Núm. 7

  5. p-21 activated kinase 4 (PAK4) role in pancreatic cancer stem cells

    Translational Cancer Research

2015

  1. Pharmacogenomic biomarkers for colorectal cancer treatment

    Cancer Treatment Communications

  2. Retinoic acid reduces stem cell-like features in pancreatic cancer cells

    Pancreas, Vol. 44, Núm. 6, pp. 918-924

2014

  1. Characteristics of adenomas detected by fecal immunochemical test in colorectal cancer screening

    Cancer Epidemiology Biomarkers and Prevention, Vol. 23, Núm. 9, pp. 1884-1892

  2. Clinical relevance of KRAS mutations in codon 13: Where are we?

    Cancer Letters

  3. Corrigendum to Clinical relevance of KRAS mutations in codon 13: Where are we? [Cancer Lett. 343 (1 (2013) 1-5]

    Cancer Letters

  4. Current approaches for predicting a lack of response to Anti-EGFR therapy in KRAS wild-type patients

    BioMed Research International, Vol. 2014